Which inflammatory mediator is known to have reduced levels after arthrocentesis?

Which inflammatory mediator is known to have reduced levels after arthrocentesis?

• A. Interleukin-6
• B. TNF-alpha
• C. Prostaglandin E2
• D. Matrix metalloproteinase-1

Answer: (B)

After performing an arthrocentesis, studies have shown that there is a reduction in the levels of TNF-alpha (tumor necrosis factor-alpha), which plays a significant role in mediating inflammation. TNF-alpha is a cytokine that is responsible for systemic inflammation and is one of the key players in the inflammatory response, particularly in conditions such as arthritis. During arthrocentesis, the procedure provides therapeutic benefits not only by aspirating excess synovial fluid, which may contain inflammatory mediators, but also by directly reducing the inflammatory load in the joint. The decrease in TNF-alpha levels indicates a reduction in the inflammatory response within the joint following the procedure. This helps alleviate pain and restore function in the affected area. In contrast, other inflammatory mediators like interleukin-6, prostaglandin E2, and matrix metalloproteinase-1 may not show similar reductions post-arthrocentesis, as their levels can remain elevated due to ongoing inflammation or other underlying conditions affecting the joint. Therefore, the notable reduction of TNF-alpha after arthrocentesis highlights its significance in the management of inflammatory arthropathy.

After performing an arthrocentesis, studies have shown that there is a reduction in the levels of TNF-alpha (tumor necrosis factor-alpha), which plays a significant role in mediating inflammation. TNF-alpha is a cytokine that is responsible for systemic inflammation and is one of the key players in the inflammatory response, particularly in conditions such as arthritis.

During arthrocentesis, the procedure provides therapeutic benefits not only by aspirating excess synovial fluid, which may contain inflammatory mediators, but also by directly reducing the inflammatory load in the joint. The decrease in TNF-alpha levels indicates a reduction in the inflammatory response within the joint following the procedure. This helps alleviate pain and restore function in the affected area.

In contrast, other inflammatory mediators like interleukin-6, prostaglandin E2, and matrix metalloproteinase-1 may not show similar reductions post-arthrocentesis, as their levels can remain elevated due to ongoing inflammation or other underlying conditions affecting the joint. Therefore, the notable reduction of TNF-alpha after arthrocentesis highlights its significance in the management of inflammatory arthropathy.